Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong You

Showing results (861-870 of 904) with videos related to

Pageof 91
Sort By:
Bioorganic Chemistry|April 6, 2021
Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodiesHong-Yang Chuang, Chiu-Chen Huang, Ting-Chun Hung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 18, 2020
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesteraseHong You, Johannes U Mayer, Rebecca L Johnston, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
Journal of Hepatology|December 10, 2019
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic targetShaoping She, Xiaoning Wu, Danfeng Zheng, et al.
Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 14, 2019
Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injuryQiu-Ju Tian, Xin-Yan Zhao, Yan Wang, et al.
Scientific Reports|November 29, 2016
Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis BHong You, Yuanyuan Kong, Jinlin Hou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2024
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory studyHai-Yang Yuan, Xiao-Fei Tong, Ya-Yun Ren, et al.
Frontiers in Immunology|April 20, 2019
Field Testing Integrated Interventions for Schistosomiasis Elimination in the People's Republic of China: Outcomes of a Multifactorial Cluster-Randomized Controlled TrialGail M Williams, Yue-Sheng Li, Darren J Gray, et al.
Pageof 91

Showing results (861-870 of 904) with videos related to

Sort By:
Pageof 91
Bioorganic Chemistry|April 6, 2021
Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodiesHong-Yang Chuang, Chiu-Chen Huang, Ting-Chun Hung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 18, 2020
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesteraseHong You, Johannes U Mayer, Rebecca L Johnston, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
Journal of Hepatology|December 10, 2019
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic targetShaoping She, Xiaoning Wu, Danfeng Zheng, et al.
Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 14, 2019
Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injuryQiu-Ju Tian, Xin-Yan Zhao, Yan Wang, et al.
Scientific Reports|November 29, 2016
Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis BHong You, Yuanyuan Kong, Jinlin Hou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2024
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory studyHai-Yang Yuan, Xiao-Fei Tong, Ya-Yun Ren, et al.
Frontiers in Immunology|April 20, 2019
Field Testing Integrated Interventions for Schistosomiasis Elimination in the People's Republic of China: Outcomes of a Multifactorial Cluster-Randomized Controlled TrialGail M Williams, Yue-Sheng Li, Darren J Gray, et al.
Pageof 91